Literature DB >> 6292496

Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

N Balachandran, D Harnish, W E Rawls, S Bacchetti.   

Abstract

We used monoclonal antibodies reacting with glycoproteins specified by herpes simplex virus type 2 (HSV-2) to characterize the individual antigens in terms of structure, processing, and kinetics of synthesis in BHK or Vero infected cells. Our results provided a direct demonstration of the structural identity of the gA and gB proteins of HSV-2 as well as confirmation of the existence of type-specific and type-common domains within the gD molecule. They also show that, with the exception of gC, processing of the viral glycoproteins differs to some extent in Vero and BHK infected cells, possibly as a result of different efficiency of glycosylation or different processing of underglycosylated and unglycosylated products in the two cell types. Finally, we showed that individual HSV-2 glycoproteins are synthesized at greatly different times during the infectious cycle, possibly in response to their different roles in virus replication and assembly.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292496      PMCID: PMC256269     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

3.  Some properties of recombinants between type 1 and type 2 herpes simplex viruses.

Authors:  I W Halliburton; R E Randall; R A Killington; D H Watson
Journal:  J Gen Virol       Date:  1977-09       Impact factor: 3.891

4.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Antigenic differences between isolates of herpesvirus type 2.

Authors:  P Seth; W E Rawls; R Duff; F Rapp; E Adam; J L Melnick
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

6.  Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.

Authors:  H McClung; P Seth; W E Rawls
Journal:  Am J Epidemiol       Date:  1976-08       Impact factor: 4.897

7.  Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.

Authors:  J W Smith; S P Lowry; J L Melnick; W E Rawls
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

8.  Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.

Authors:  G H Cohen; M Katze; C Hydrean-Stern; R J Eisenberg
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

9.  Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus.

Authors:  B Norrild; H Ludwig; R Rott
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

10.  Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells.

Authors:  H Koprowski; W Gerhard; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  49 in total

1.  Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C.

Authors:  C Seidel-Dugan; M Ponce de Leon; H M Friedman; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart.

Authors:  M A Swain; R W Peet; D A Galloway
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.

Authors:  M F Para; M L Parish; A G Noble; P G Spear
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.

Authors:  S R Jennings; P A Lippe; K J Pauza; P G Spear; L Pereira; S S Tevethia
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes.

Authors:  V C Carter; S R Jennings; P L Rice; S S Tevethia
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.

Authors:  R L Ashley; L Corey
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein.

Authors:  K M Zezulak; P G Spear
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes.

Authors:  R J Watson; A M Colberg-Poley; C J Marcus-Sekura; B J Carter; L W Enquist
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.